Eli Lilly’s Alzheimer’s Drug Kisunl...

By HEOR Staff Writer

September 30, 2024

Introduction Eli Lilly has achieved a milestone with its Alzheimer's drug Kisunla, recently approved by Japan's health ministry. Donanemab (Kisunla) is an antibody drug designe...
Dementia Prevention in Latin America: A Focus on Modifiable Risk Factors
Alzheimer’s Treatments: Evaluating Emerging Therapies and NICE’s ...
In Saudi Arabia, the Hevolution Foundation is Reshaping Ageing Research
Artificial Intelligence in Elderly Care: Ethical and Responsible Adoption
The Impact of Immunosenescence on Ageing
Healthcare Needs of Sub-Saharan Africa’s Ageing Population
New Innovations in Elderly Healthcare: Latest PBAC Outcomes
Caring for an Ageing US Population: Challenges and Innovations
Impact of Social Support on Quality of Life Among the Elderly
Remote Health Assessments with Multimodal Technologies
Abu Dhabi Strategic Healthcare Partnerships: Global Collaborations
Economic Evaluations for Dementia Interventions